Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial

Journal:
The Lancet Oncology
Published:
DOI:
10.1016/s1470-2045(25)00380-8
Affiliations:
20
Authors:
30
Go to article
Institutions Authors Share
The University of Texas MD Anderson Cancer Center, United States of America (USA)
26.000000
26.000000
26.000000
 0.87
Myriad Genetics, Inc., United States of America (USA)
4.000000
 0.13
Interested in Oncology and Carcinogenesis?